Thrombosis Research, 0049-3848
Journal
1 - 50 out of 68Page size: 50
- 2019
- Croles, F. N., Lukens, M. V., Mulder, R., de Maat, M. P. M., Mulder, A. B., & Meijer, K. (2019). Monitoring of heparins in antithrombin-deficient patients. Thrombosis Research, 175, 8-12. https://doi.org/10.1016/j.thromres.2019.01.007
- PALLADIO Study Investigators, Riva, N., Righini, M., Camporese, G., Iotti, M., Bucherini, E., ... Ageno, W. (2019). Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly. Thrombosis Research, 174, 148-150. https://doi.org/10.1016/j.thromres.2018.12.024
- 2018
- RIETE Investigators, Moustafa, F., Stehouwer, A., Kamphuisen, P., Carles Sahuquillo, J., Samperiz, A., ... Monreal, M. (2018). Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism. Thrombosis Research, 171, 74-80. https://doi.org/10.1016/j.thromres.2018.09.049
- Lameijer, H., Aalberts, J. J. J., van Veldhuisen, D. J., Meijer, K., & Pieper, P. G. (2018). Efficacy and safety of direct oral anticoagulants during pregnancy; a systematic literature review. Thrombosis Research, 169, 123-127. https://doi.org/10.1016/j.thromres.2018.07.022
- Croles, F. N., Mulder, R., Mulder, A. B., Lukens, M. V., & Meijer, K. (2018). beta-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study. Thrombosis Research, 168, 47-52. https://doi.org/10.1016/j.thromres.2018.06.004
- Moesker, M. J., Damen, N. L., Volmeijer, E. E., Dreesens, D., de Loos, E. M., Vink, R., ... Wagner, C. (2018). Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal. Thrombosis Research, 168, 5-13. https://doi.org/10.1016/j.thromres.2018.05.028
- van Pelt, L. J., Lukens, M. V., Testa, S., Chatelain, B., Douxfils, J., & Mullier, F. (2018). The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs. Thrombosis Research, 168, 63-66. https://doi.org/10.1016/j.thromres.2018.04.024
- van Es, N., Hisada, Y., Di Nisio, M., Cesarman, G., Kleinjan, A., Mahe, I., ... Nieuwland, R. (2018). Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thrombosis Research, 166, 54-59. https://doi.org/10.1016/j.thromres.2018.04.009
- 2017
- Wilts, I. T., Hutten, B. A., Meijers, J. C. M., Spek, C. A., Buller, H. R., & Kamphuisen, P. W. (2017). Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer. Thrombosis Research, 154, 15-20. https://doi.org/10.1016/j.thromres.2017.03.001
- Wilts, I. T., Le Gal, G., Den Exter, P. L., Van Es, J., Carrier, M., Planquette, B., ... Kamphuisen, P. W. (2017). Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism. Thrombosis Research, 152, 49-51. https://doi.org/10.1016/j.thromres.2017.02.007
- Lisman, T., & Bernal, W. (2017). Hemostatic issues in pregnancy-induced liver disease. Thrombosis Research, 151(Suppl. 1), S78-S81. https://doi.org/10.1016/S0049-3848(17)30073-7
- Bos, S., Potze, W., Siddiqui, M. S., Boyett, S. L., Adelmeijer, J., Daita, K., ... Sanyal, A. J. (2017). Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease. Thrombosis Research, 150, 41-43. https://doi.org/10.1016/j.thromres.2016.12.008
- 2016
- van Es, N., Bleker, S. M., Di Nisio, M., Kleinjan, A., Beyer-Westendorf, J., Camporese, G., ... Bossuyt, P. M. (2016). A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients For the ARMOUR study investigators. Thrombosis Research, 148, 59-62. https://doi.org/10.1016/j.thromres.2016.10.019
- Tichelaar, Y. I. G. V., & Lijfering, W. M. (2016). Who is at high risk of recurrent venous thrombosis and do they really benefit from continuation of anticoagulation? Clinicians wield a double-edged sword that might cut nothing at all. Thrombosis Research, 143, 150-+. https://doi.org/10.1016/j.thromres.2016.05.006
- Isaksen, T., Tichelaar, Y. I. G. V., Skjeldestad, F. E., Brodin, E. E., Vik, A., Singh, K., & Hansen, J-B. (2016). Inter-rater agreement between professional-rated and patient-rated scores of the Villalta scale for evaluation of the post-thrombotic syndrome. Thrombosis Research, 141, 175-177. https://doi.org/10.1016/j.thromres.2016.03.027
- Kleiss, S. F., Adelmeijer, J., Meijers, J. C. M., Porte, R. J., & Lisman, T. (2016). A sustained decrease in plasma fibrinolytic potential following partial liver resection or pancreas resection. Thrombosis Research, 140, 36-40. https://doi.org/10.1016/j.thromres.2016.02.011
- Svilaas, T., Lefrandt, J., Gietema, J., & Kamphuisen, P. W. (2016). Long-term arterial complications of chemotherapy in patients with cancer. Thrombosis Research, 140 (Supplement 1), S109-S118. https://doi.org/10.1016/S0049-3848(16)30109-8
- Sneeboer, M. M. S., Hutten, B. A., Majoor, C. J., Bel, E. H. D., & Kamphuisen, P. W. (2016). Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism. Thrombosis Research, 140, 46-50. https://doi.org/10.1016/j.thromres.2016.02.010
- 2015
- ten Cate-Hoek, A. J., Weitz, J. I., Gailani, D., Meijer, K., Philippou, H., Bouman, A. C., ... Buller, H. R. (2015). Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS). Thrombosis Research, 136, S13-S18. https://doi.org/10.1016/j.thromres.2015.07.036
- van Es, J., Douma, R. A., Hezemans, R. E. L., Penaloza, A., Motte, S., Erkens, P. G. M., ... Kamphuisen, P. W. (2015). Accuracy of X-ray with perfusion scan in young patients with suspected pulmonary embolism. Thrombosis Research, 136(2), 221-224. https://doi.org/10.1016/j.thromres.2015.05.018
- Potze, W., Adelmeijer, J., Porte, R. J., & Lisman, T. (2015). Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis. Thrombosis Research, 135(5), 1012-1016. https://doi.org/10.1016/j.thromres.2015.02.025
- Mulder, R., Croles, F. N., Lukens, M. V., Meijer, K., & Mulder, A. B. (2015). A novel c.290G > A mutation in the Factor 11 gene in a Dutch Caucasian family with a Factor XI deficiency. Thrombosis Research, 135(4), 767-769. https://doi.org/10.1016/j.thromres.2015.01.014
- Alkozai, E. M., Porte, R. J., Adelmeijer, J., Zanetto, A., Simioni, P., Senzolo, M., & Lisman, T. (2015). No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma. Thrombosis Research, 135(2), 292-297. https://doi.org/10.1016/j.thromres.2014.11.016
- 2014
- Riva, N., Ageno, W., Schulman, S., Bang, S. M., Teresa Sartori, M., Grandone, E., ... Dentali, F. (2014). Vitamin K antagonists versus heparin for the treatment of splanchnic vein thrombosis in the ISTH registry: Results of 12-month follow-up and a propensity score analysis. Thrombosis Research, 134, 34-35.
- Mos, I. C. M., Douma, R. A., Erkens, P. M. G., Kruip, M. J. H. A., Hovens, M. M., van Houten, A. A., ... Prometheus Study Grp (2014). Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm. Thrombosis Research, 133(6), 1039-1044. https://doi.org/10.1016/j.thromres.2014.03.050
- Kamphuisen, P. W., & Beyer-Westendorf, J. (2014). Bleeding complications during anticoagulant treatment in patients with cancer. Thrombosis Research, 133(SUPPL. 2), S49-S55. https://doi.org/10.1016/S0049-3848(14)50009-6
- Van Der Hulle, T., Den Exter, P., Mos, I., Kamphuisen, P., Hovens, M., Kruip, M., ... Klok, E. (2014). C0197: Optimization of the diagnostic management of clinically suspected pulmonary embolism in hospitalized patients. Thrombosis Research, 133, 32. https://doi.org/10.1016/S0049-3848(14)50118-1
- van Es, N., Bleker, S. M., Di Nisio, M., Kamphuisen, P. W., Otten, H. M., Mahe, I., ... Buller, H. R. (2014). External validation of current VTE risk prediction scores for patients with solid cancer in an ongoing prospective multicenter cohort study. Thrombosis Research, 133, S208-S209.
- Willemze, R., Bradford, R. L., Mooberry, M. J., Roubey, R. A. S., & Key, N. S. (2014). Plasma Microparticle Tissue Factor Activity in Patients With Antiphospholipid Antibodies With and Without Clinical Complications. Thrombosis Research, 133(2), 187-189. https://doi.org/10.1016/j.thromres.2013.11.027
- 2013
- van Es, J., den Exter, P. L., Kaptein, A. A., Andela, C. D., Erkens, P. M. G., Klok, F. A., ... Middeldorp, S. (2013). Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL. Thrombosis Research, 132(5), 500-505. https://doi.org/10.1016/j.thromres.2013.06.016
- 2012
- Krzek, M., Ciesla-Dul, M., Zabczyk, M., & Undas, A. (2012). Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives. Thrombosis Research, 130(4), 216-221. [10.1016/j.thromres.2012.08.302]. https://doi.org/10.1016/j.thromres.2012.08.302
- Knol, H. M., Schultinge, L., Veeger, N. J. G. M., Kluin-Nelemans, H. C., Erwich, J. J. H. M., & Meijer, K. (2012). The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy. Thrombosis Research, 130(3), 334-338. https://doi.org/10.1016/j.thromres.2012.03.007
- Huet, R. C. G. G., Cernak, V., de Vries, A. J., & Lisman, T. (2012). Bivalirudin is inferior to heparin in preservation of intraoperative autologous blood. Thrombosis Research, 130(2), 163-165. https://doi.org/10.1016/j.thromres.2011.12.024
- Kleinjan, A., Aggerwal, A., Van Der Geer, A., Kamphuisen, P. W., Rickles, F. R., Faselis, C., & Büller, H. R. (2012). A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism. Thrombosis Research, 129, 183. https://doi.org/10.1016/S0049-3848(12)70109-3
- Kleinjan, A., Berckmans, R. J., Böing, A. N., Sturk, A., Büller, H. R., Kamphuisen, P. W., & Nieuwland, R. (2012). Cellular origin and procoagulant activity of tissue factor-exposing microparticles in cancer patients. Thrombosis Research, 129, 161. https://doi.org/10.1016/S0049-3848(12)70049-X
- Tichelaar, V., Mulder, A., Kluin-Nelemans, H., & Meijer, K. (2012). The acute phase reaction explains only a part of initially elevated factor VIII: C levels: A prospective cohort study in patients with venous thrombosis. Thrombosis Research, 129(2), 183-186. https://doi.org/10.1016/j.thromres.2011.09.024
- Mahmoodi, B. K., Nijsten, M., Wijsman, J., Matthews, A. G., & van der Laan, L. (2012). ABO-blood groups and risk of abdominal aortic aneurysm and peripheral obstructive artery disease: Two sides of the same coin. Thrombosis Research, 129(1), 89-90. https://doi.org/10.1016/j.thromres.2011.09.028
- 2011
- Mulder, R., Tichelaar, V. Y. I. G., Lijfering, W. M., Kluin-Nelemans, H. C., Mulder, A. B., & Meijer, K. (2011). Decreased free protein S levels and venous thrombosis in the acute setting, a case-control study. Thrombosis Research, 128(5), 501-502. https://doi.org/10.1016/j.thromres.2011.06.015
- Resh, M., Mahmoodi, B. K., Navis, G. J., Veeger, N. J. G. M., & Lijfering, W. M. (2011). Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism. Thrombosis Research, 127(5), 395-399. https://doi.org/10.1016/j.thromres.2010.12.020
- de Groot, P. G. (2011). Mechanisms of anti-phospholipid antibody formation and action. Thrombosis Research, 127, S40-S42.
- 2010
- Mulder, R., van Schouwenburg, I. M., Mahmoodi, B. K., Veeger, N. J. G. M., Mulder, A. B., Middeldorp, S., ... Lijfering, W. M. (2010). Associations between high factor VIII and low free protein S levels with traditional arterial thrombotic risk factors and their risk on arterial thrombosis: Results from a retrospective family cohort study. Thrombosis Research, 126(4), E249-E254. https://doi.org/10.1016/j.thromres.2010.07.013
- Douma, R. A., Kok, M. G. M., Verberne, L. M., Kamphuisen, P. W., & Büller, H. R. (2010). Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thrombosis Research, 125(6), e306-e309. https://doi.org/10.1016/j.thromres.2010.02.010
- Borensztajn, K., Peppelenbosch, M. P., & Spek, C. A. (2010). Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation. Thrombosis Research, 125(6), E323-E328. https://doi.org/10.1016/j.thromres.2010.02.018
- Nossent, A. Y., Ellenbroek, J. H., Frölich, M., Bertina, R. M., Knoers, N. V. A. M., & Eikenboom, J. C. J. (2010). Plasma levels of von Willebrand factor, von Willebrand factor propeptide and factor VIII in carriers and patients with nephrogenic diabetes insipidus. Thrombosis Research, 125(6), 554-556. https://doi.org/10.1016/j.thromres.2010.03.014
- Kleinjan, A., Di Nisio, M., Kamphuisen, P. W., & Büller, H. R. (2010). Safety and feasibility of a diagnostic algorithm combining clinical probability, D-dimer test and ultrasonography in suspected upper extremity deep vein thrombosis. Thrombosis Research, 125, 169. https://doi.org/10.1016/S0049-3848(10)70062-1
ID: 2015386